Fleury S.A.

Equities

FLRY3

BRFLRYACNOR5

Healthcare Facilities & Services

Market Closed - Sao Paulo Other stock markets 16:07:37 2024-05-16 EDT			5-day change	1st Jan Change
14.67 ^BRL	+4.71%		-0.54%	-18.68%

05-10	Fleury Seeks Acquisitions	CI
05-10	Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024

Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

April 29, 2021 at 06:21 pm

Fleury S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced net income was BRL 118.612 million compared to BRL 58.719 million a year ago.

Latest news about Fleury S.A.

Fleury Seeks Acquisitions	05-10	CI
Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024	05-10
Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Fleury S.A. entered into a Share Purchase and Sale Agreement to acquire São Lucas Centro de Diagnosis for an Enterprise value of BRL 69.8 million.	04-21	CI
Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024	03-08
Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-07	CI
Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-06	CI
Fleury S.A Seeks Inorganic Growth	11-10	CI
Transcript : Fleury S.A., Q3 2023 Earnings Call, Nov 10, 2023	11-10
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Fleury Seeks Inorganic Growth	23-08-04	CI
Transcript : Fleury S.A., Q2 2023 Earnings Call, Aug 04, 2023	23-08-04
Fleury S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Transcript : Fleury S.A., Q1 2023 Earnings Call, May 05, 2023	23-05-05
Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03	CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others.	23-04-27	CI
Transcript : Fleury S.A., Q4 2022 Earnings Call, Mar 17, 2023	23-03-17
Fleury S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-16	CI
Transcript : Fleury S.A., Q3 2022 Earnings Call, Nov 04, 2022	22-11-04
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
Brazil's Fleury gets green light for capital increase of up to $229 mln	22-10-17	RE
Brazil's Fleury gets green light for capital increase of up to $229 mln	22-10-17	RE
Fleury S.A. completed the acquisition of Methodos laboratory in Minas Gerais.	22-10-03	CI
C2N Diagnostics LLC Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health	22-09-21	CI
Transcript : Fleury S.A., Q2 2022 Earnings Call, Aug 05, 2022	22-08-05

Chart Fleury S.A.

Duration

Period

More charts

Company Profile

Fleury S.A. specializes in clinical diagnosis, treatment and analysis services. At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.

Sector

Healthcare Facilities & Services

Calendar

2024-06-04 - Bradesco BBI London Conference

Related indices

BRAZIL IBOVESPA

More about the company

Income Statement Evolution

More financial data

Ratings for Fleury S.A.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.35 BRL

Average target price

19.33 BRL

Spread / Average Target

+34.73%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
FLEURY S.A.	-18.68%	1.53B
SONIC HEALTHCARE LIMITED	-15.71%	8.57B
RADNET, INC.	+65.60%	4.3B
SYNLAB AG	-9.46%	2.47B
DR. LAL PATHLABS LIMITED	-2.16%	2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.11%	2.31B
NEOGENOMICS, INC.	-7.42%	1.93B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-41.75%	1.2B
METROPOLIS HEALTHCARE LIMITED	+11.31%	1.14B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+16.15%	986M

Medical & Diagnostic Laboratories